L-Threonine derivatives of high therapeutic index
AssigneeSignature R&D Holdings, LLC
InventorV. Ravi Chandran
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a derivative comprised of an L-Threonine bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. The derivative has the same utility as the drug from which it is made, but it has enhanced therapeutic properties. In fact, the derivatives of the present invention enhance at least one or more therapeutic qualities, as defined herein. The present invention is also directed to pharmaceutical compositions containing same.
Claims3
A method for enhancing the therapeutic index of a drug having a functionality group selected form the group consisting of hydroxy, carboxy or acylating derivatives of said carboxy group
- the method comprising administering to a mammal a L-Threonine ester of said drug, wherein the drug is Abacavir, Acarbose, Acebutolol, Acetaminophen, Adefovir, Albuterol, Alfaprostol Acid, Amoxicillin, Amphotericin B, Amprenavir, Arachidonic Acid, Aspirin, Atenolol, Atorvastatin, Atropine, Atovaquone, Baclofen, Benazeprilat, Beraprost, Betaxolol, Bexarotene, Bicalutamide, Biotin, Biperiden, Bisoprolol, Bitolterol, Brinzolamide, Buprenorphine, Butorphanol, Candesartan, Capacitabine, Captopril, Carbidopa, Carboprost, Carnitine, Carteolol, Carvedilol, Cefdinir, Cefditoren, Ceftazimide, Cefpodoxime, Cefuroxime, Cerivastatin, Chloramphenicol, Ciprofloxacin, Clopidogrel Acid, Cloprostenol, Clorazepic Acid, Cyclosporine, Cytarabine, Danazol, Dextroamphetamine, Diclofenac, Didanosine, Digoxin, Divalproex, Docetaxel, Dyphylline, Enalaprilat, Ephedrine, Eplerenone, Eprosartan, Esmolol, Estramustine, Ethambutol, Ethchlorvynol, Etoposide, Ezetimibe, Fenofibrate, Fenoprofen, Fenprostalene Acid, Fexofenadine, Fibric Acid derivatives, Fluprostenol, Flurbiprofen, Fluticasone, Fluvastatin, Folic Acid, Fosinoprilat, Frovatriptan, Fulvestrant, Gabapentin, Gemprost Acid, Ganciclovir, Goserelin, 5-HETE, Hydroxychloroquine, Hydroxyzine, Hyoscyamine, Ibuprofen, Ibutilide, Indinavir, Ipratropium, Irinotecan, Isosorbide, Ketoprofen, Ketorolac, Labetalol, Lamivudine, Lansoprazole, Latanoprost Acid, Leuprolide, Leukotrienes, Levobunolol, Levodopa, Levorphanol, Υ-Linolenic Acid, Limaprost, Liothyronine, Lisinopril, Lopinavir, Lorazepam, Lovastatin, Medroxyprogesterone, Mefloquine, Megestrol, Metaproterenol, Methohexital, Methotrexate, Methylphenidate, Methylprednisolone, Metoprolol, Mexiletine, Miglitol, Moexiprilat, Mometasone, Montelukast, Mycophenolate Acid, Nadolol, Nalbuphine, Naproxen, Nateglinide, Nelfinavir, Niacin, Nicotinic Acid, Norgestimate, Octreotide, Ofloxacin, Olmesartan, Ozagrel, Paclitaxel, Pantothenic Acid, Penbutolol, Penicillamine, Penciclovir, Pentazocine, Perindoprilat, Phenylephrine, Phenylpropanolamine, Pimecrolimus, Pindolol, Pirbuterol, Pravastatin, Propafenone, Propofol, Propranolol, Prostgandins E1, E2 and F2α, Prostanoic Acid, Pseudoephedrine, Quinaprilat, Quinidine, Quinine, Ramiprilat, Repaglinide, Ribavirin, Ritonavir, Rosaprostol, Rosuvastatin, Salmeterol, Salicylic Acid, Salsalate, Simavastatin, Sirolimus, Sotalol, Sulfa Drugs, Sulfasalazine, Tacrolimus, Tazorotene, Telmesartan, Tenofovir, Terbutaline, Thyroxine, Tiagabine, Timolol, Tirofiban, Tramadol, Trandolaprilat, Tranylcypromine, Treprostinil, Triamcinolone, Trimoprostil, Troglitazone, Unoprostone, Valsartan, Valproic Acid, Venlafaxine, Vidarabine, Warfarin, Zalcitabine, or Zidovudine, wherein said L-Threonine ester of said drug has an enhanced therapeutic index relative to said drug.
Dependencies are inferred from the claim text.